Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


18.03.2024

1 Antimicrob Agents Chemother
1 Arch Virol
1 Biochem Biophys Res Commun
1 Biochemistry (Mosc)
1 BMC Pediatr
1 BMJ
1 Drug Saf
3 J Clin Microbiol
1 J Immunol
1 J Infect
8 J Infect Dis
3 J Virol
4 JAMA
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
31 PLoS One
1 Proc Natl Acad Sci U S A
3 Vaccine
3 Virology
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. YU Y, Chen S, Zhang H, Duan Y, et al
    A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection.
    Antimicrob Agents Chemother. 2024 Mar 12:e0135023. doi: 10.1128/aac.01350.
    PubMed         Abstract available


    Arch Virol

  2. YUAN J, Pan J, Zhang X, Gao R, et al
    TRIM21 reduces H1N1-induced inflammation and apoptosis by regulating the TBK1-IRF3 signaling pathway in A549 cells.
    Arch Virol. 2024;169:74.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  3. KIM HJ, Han CW, Jeong MS, Jang SB, et al
    Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex.
    Biochem Biophys Res Commun. 2024;706:149728.
    PubMed         Abstract available


    Biochemistry (Mosc)

  4. GABDOULKHAKOVA AG, Mingaleeva RN, Romozanova AM, Sagdeeva AR, et al
    Immunology of SARS-CoV-2 Infection.
    Biochemistry (Mosc). 2024;89:65-83.
    PubMed         Abstract available


    BMC Pediatr

  5. HOSEININASAB A, Sinaei R, Bagheri MM, Ahmadipour M, et al
    Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes.
    BMC Pediatr. 2024;24:179.
    PubMed         Abstract available


    BMJ

  6. WILKINSON E
    Covid inquiry: What we have learnt about Wales's response?
    BMJ. 2024;384:q608.
    PubMed        


    Drug Saf

  7. DOS SANTOS G, Devadiga R, Kim CS, Bang J, et al
    An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged
    Drug Saf. 2024 Mar 14. doi: 10.1007/s40264-024-01395.
    PubMed         Abstract available


    J Clin Microbiol

  8. KONDGEN S, Oh D-Y, Thurmer A, Sedaghatjoo S, et al
    A robust, scalable, and cost-efficient approach to whole genome sequencing of RSV directly from clinical samples.
    J Clin Microbiol. 2024;62:e0111123.
    PubMed         Abstract available

  9. PEAPER DR, Doern CD, Sharp S
    Proceedings of the Clinical Microbiology Open 2022-assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1).
    J Clin Microbiol. 2024;62:e0094123.
    PubMed         Abstract available

  10. HICKMAN R, Nguyen J, Lee TD, Tyson JR, et al
    Rapid, high-throughput, cost-effective whole-genome sequencing of SARS-CoV-2 using a condensed library preparation of the Illumina DNA Prep kit.
    J Clin Microbiol. 2024;62:e0010322.
    PubMed         Abstract available


    J Immunol

  11. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    PubMed         Abstract available


    J Infect

  12. DOWELL AC, Tut G, Begum J, Bruton R, et al
    Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
    J Infect. 2023 Sep 1:S0163-4453(23)00465-6. doi: 10.1016/j.jinf.2023.
    PubMed         Abstract available


    J Infect Dis

  13. ALI YM, Carnell GW, Fumagalli S, Mercurio D, et al
    Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.
    J Infect Dis. 2024;229:680-690.
    PubMed         Abstract available

  14. RUDOLPH AE, Khan FL, Shah A, Singh TG, et al
    Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against symptomatic COVID-19 among immunocompetent individuals testing at a large US retail pharmacy.
    J Infect Dis. 2023 Oct 31:jiad474. doi: 10.1093.
    PubMed         Abstract available

  15. BAY P, Loegel C, Ly A, Soulier A, et al
    Clinical Phenotypes and Molecular Characteristics of Respiratory Syncytial Virus in Adults: A Monocentric Prospective Study Between 2019 and 2022.
    J Infect Dis. 2024;229:728-732.
    PubMed         Abstract available

  16. JENSEN TO, Grandits GA, Jain MK, Murray TA, et al
    Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
    J Infect Dis. 2024;229:671-679.
    PubMed         Abstract available

  17. LI X, Zhou G, Sun X, Qu S, et al
    NLRP12 Senses the SARS-CoV-2 Membrane Protein and Promotes an Inflammatory Response.
    J Infect Dis. 2024;229:660-670.
    PubMed         Abstract available

  18. ROSSLER A, Knabl L, Netzl A, Bante D, et al
    Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.
    J Infect Dis. 2024;229:644-647.
    PubMed         Abstract available

  19. FINSTERER J
    Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment.
    J Infect Dis. 2024;229:918-919.
    PubMed        

  20. SCOTT N, Martinovich KM, Granland CM, Seppanen EJ, et al
    Nasal Delivery of Haemophilus haemolyticus Is Safe, Reduces Influenza Severity, and Prevents Development of Otitis Media in Mice.
    J Infect Dis. 2024 Mar 12:jiae069. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  21. SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
    Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
    J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
    PubMed         Abstract available

  22. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    PubMed         Abstract available

  23. WEN F, Yan Z, Chen G, Chen Y, et al
    Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
    J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
    PubMed         Abstract available


    JAMA

  24. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    PubMed        

  25. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    PubMed        

  26. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    PubMed        

  27. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  28. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    PubMed         Abstract available


    N Engl J Med

  29. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    PubMed         Abstract available


    PLoS One

  30. GRACIOUS PD, Armah J, Boateng EA, Bam V, et al
    Expectations, experiences and challenges of nursing students using the virtual learning medium during the COVID-19 pandemic: A descriptive phenomenological study.
    PLoS One. 2024;19:e0299967.
    PubMed         Abstract available

  31. FULHAM-MCQUILLAN H, O'Donovan R, Buckley CM, Crowley P, et al
    Exploring the needs and experiences of contact tracing staff during the COVID-19 pandemic in Ireland.
    PLoS One. 2024;19:e0298799.
    PubMed         Abstract available

  32. BUTLER MJ, Chiuzan C, Ahn H, Gao M, et al
    Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults.
    PLoS One. 2024;19:e0286371.
    PubMed         Abstract available

  33. SENJAM SS, Manna S, Goel G, Balhara YPS, et al
    Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
    PLoS One. 2024;19:e0299564.
    PubMed         Abstract available

  34. SIMPSON E, Miller WC, Schmidt J, Borisoff J, et al
    Changes in functioning and health during the first 6-months of the COVID-19 pandemic among individuals with a spinal cord injury.
    PLoS One. 2024;19:e0299570.
    PubMed         Abstract available

  35. MAJ A, Matynia M, Michalak N, Bis A, et al
    New in Town-An internet-based self-efficacy intervention for internal migrants: A randomized controlled trial.
    PLoS One. 2024;19:e0299638.
    PubMed         Abstract available

  36. TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
    Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
    PLoS One. 2024;19:e0296812.
    PubMed         Abstract available

  37. FREITAS DHM, Costa ELV, Zimmermann NA, Gois LSO, et al
    Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves.
    PLoS One. 2024;19:e0299607.
    PubMed         Abstract available

  38. SINTO R, Lie KC, Setiati S, Suwarto S, et al
    Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital.
    PLoS One. 2024;19:e0297405.
    PubMed         Abstract available

  39. ROUCOUX G, Thonon F, Zucman D, Rey D, et al
    Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
    PLoS One. 2024;19:e0295223.
    PubMed         Abstract available

  40. GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
    Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
    PLoS One. 2024;19:e0300198.
    PubMed         Abstract available

  41. PESTANA D, Moura K, Moura C, Mouliakis T, et al
    The impact of COVID-19 workload on psychological distress amongst Canadian intensive care unit healthcare workers during the 1st wave of the COVID-19 pandemic: A longitudinal cohort study.
    PLoS One. 2024;19:e0290749.
    PubMed         Abstract available

  42. ZHANG X, Han X, Chen B, Fu X, et al
    Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
    PLoS One. 2024;19:e0289255.
    PubMed         Abstract available

  43. SHERMAN SA, Quinn TD, Bock BC, Braun TD, et al
    Perceived delivery of essential yoga properties within in-person and remote weight loss maintenance interventions.
    PLoS One. 2024;19:e0300105.
    PubMed         Abstract available

  44. POOL M, Sorsdahl K, Myers B, van der Westhuizen C, et al
    The prevalence of and factors associated with depressive and anxiety symptoms during the COVID-19 pandemic among healthcare workers in South Africa.
    PLoS One. 2024;19:e0299584.
    PubMed         Abstract available

  45. MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
    COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
    PLoS One. 2024;19:e0299568.
    PubMed         Abstract available

  46. MAMRATH S, Greenfield M, Fernandez Turienzo C, Fallon V, et al
    Experiences of postpartum anxiety during the COVID-19 pandemic: A mixed methods study and demographic analysis.
    PLoS One. 2024;19:e0297454.
    PubMed         Abstract available

  47. MADDEN D
    Mental health in Ireland during the Covid pandemic: Evidence from two longitudinal surveys.
    PLoS One. 2024;19:e0279526.
    PubMed         Abstract available

  48. RAMIREZ-MARTINEZ FR, Villanos MT, Sharma S, Leiner M, et al
    Variations in anxiety and emotional support among first-year college students across different learning modes (distance and face-to-face) during COVID-19.
    PLoS One. 2024;19:e0285650.
    PubMed         Abstract available

  49. PANG Y, Robbs C, Wang J
    A longitudinal study of the COVID-19 pandemic impact on mental health in ophthalmic personnel and students.
    PLoS One. 2024;19:e0300144.
    PubMed         Abstract available

  50. LI H, Wang C
    MIS-Net: A deep learning-based multi-class segmentation model for CT images.
    PLoS One. 2024;19:e0299970.
    PubMed         Abstract available

  51. ROSMARIN DH, Pirutinsky S
    Response to anxiety treatment before, during, and after the COVID-19 pandemic.
    PLoS One. 2024;19:e0296949.
    PubMed         Abstract available

  52. DEUTER D, Hense K, Kunkel K, Vollmayr J, et al
    SARS-CoV2 evokes structural brain changes resulting in declined executive function.
    PLoS One. 2024;19:e0298837.
    PubMed         Abstract available

  53. HEIDECKE J, Fuhrmann J, Barbarossa MV
    A mathematical model to assess the effectiveness of test-trace-isolate-and-quarantine under limited capacities.
    PLoS One. 2024;19:e0299880.
    PubMed         Abstract available

  54. MALIK H, Anees T
    Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.
    PLoS One. 2024;19:e0296352.
    PubMed         Abstract available

  55. JUTTLA PK, Ndiritu M, Milliano F, Odongo AO, et al
    Knowledge, attitudes and practices towards COVID-19 among healthcare workers: A cross-sectional survey from Kiambu County, Kenya.
    PLoS One. 2024;19:e0297335.
    PubMed         Abstract available

  56. BOAS H, Havdal LB, Stordal K, Dollner H, et al
    No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway.
    PLoS One. 2024;19:e0298104.
    PubMed         Abstract available

  57. MARTINEZ-SANCHEZ JL, Zequeira Larios C, Hernandez Ramirez F
    Affectation of COVID-19 pandemic on the use and abundance of wild resources in Tabasco, Mexico: A qualitative assessment.
    PLoS One. 2024;19:e0299744.
    PubMed         Abstract available

  58. SCHUMACHER J, Kuhne L, Brussermann S, Geisler B, et al
    COVID-19 isolation and quarantine orders in Berlin-Reinickendorf (Germany): How many, how long and to whom?
    PLoS One. 2024;19:e0271848.
    PubMed         Abstract available

  59. SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
    Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
    PLoS One. 2024;19:e0299141.
    PubMed         Abstract available

  60. DUAN S, Wang Y, Kotanko P, Zhang H, et al
    Network analysis of spread of SARS-CoV-2 within dialysis clinics: A multi-center network analysis.
    PLoS One. 2024;19:e0299855.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  61. CAHUANTZI R, Lythgoe KA, Hall I, Pellis L, et al
    Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods.
    Proc Natl Acad Sci U S A. 2024;121:e2317284121.
    PubMed         Abstract available


    Vaccine

  62. ST-LOUIS P, Martin C, Khatri V, Bourgault S, et al
    Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice.
    Vaccine. 2024 Mar 8:S0264-410X(24)00222-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  63. LUISI M, Geana MV, Pei J
    Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination.
    Vaccine. 2024 Mar 8:S0264-410X(24)00275-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


  64. Expression of Concern: "Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine" [Vaccine [33/1], 1 January 2015, Pages 108-116].
    Vaccine. 2024;42:1851.
    PubMed        


    Virology

  65. LIU J, Gao L, Zhou N, Jiang Z, et al
    p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
    Virology. 2024;593:110018.
    PubMed         Abstract available

  66. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    PubMed         Abstract available

  67. SAIKIA BK, Roy K, Konwar R
    Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
    Virology. 2024;593:110036.
    PubMed         Abstract available


    Virus Res

  68. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.